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Macroautophagy, a homeostatic process that shuttles cytoplasmic constituents into endosomal and
lysosomal compartments, has recently been shown to deliver antigens for presentation on major
histocompatibility complex (MHC) class II. Autophagy-mediated antigen processing in thymic epi-
thelial cells has been suggested to be involved in the generation of a self-MHC restricted and self-tol-
erant CD4+ T cell repertoire. Furthermore, there is accumulating evidence that the up-regulation of
autophagy by pattern-recognition receptor signaling represents an innate defense mechanism
against intracellular pathogens. Thus, through linking pathogen breakdown with the presentation
of pathogen-derived autophagy substrates on MHC class II, autophagy serves a dual function at
the interface of the innate and the adaptive immune response.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Autophagy is a homeostatic process by which cells recycle
nutrients and degrade cytoplasmic constituents such as defective
organelles and macromolecular aggregates for lysosomal degrada-
tion. There are at least three distinct pathways of autophagy:
microautophagy, chaperone-mediated autophagy (CMA) and mac-
roautophagy. Microautophagy is characterized by the uptake of
cytoplasmic components at the lysosomal membrane via budding
into the lysosome, through a poorly deﬁned mechanism. Sub-
strates for CMA carry signal peptides for sorting into lysosomes,
similar to other protein transport mechanisms across membranes,
and are directly imported into lysosomes through the LAMP-2a
transporter [1,2], assisted by cytosolic and lysosomal HSC70 chap-
erones. Macroautophagy is the major route for lysosomal degrada-
tion of cytoplasmic constituents. During macroautophagy,
cytosolic constituents including organelles are enclosed in a dou-
ble-membrane vesicle, called autophagosome [3,4], which then
fuses with late endosomal/lysosomal organelles for degradationchemical Societies. Published by E
plex; DC, dendritic cells; APC,
stein Barr virus; TEC, thymic
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lein), jan.luenemann@usz.chof the inner autophagosomal membrane and its cargo. The result-
ing breakdown products of macromolecules are subsequently re-
leased back into the cytosol through permeases in the lysosomal
membrane, where they can be reused for anabolic or catabolic
reactions [5].
Studies on the molecular mechanisms of macroautophagy and
its importance in protein metabolism [5] have set the stage to ana-
lyze its role in multiple biological processes including innate and
adaptive immune responses. In keeping with its cellular clearance
function, macroautophagy participates in limiting pathogen repli-
cation in host cells. In addition, macroautophagy delivers viral, par-
asitic, and bacterial antigens to late endosomal compartments,
where macroautophagy substrates are then degraded by lysosomal
hydrolases. The fusion vesicles between autophagosomes and late
endosomes, the so-called amphisomes, display a multivesicular
and multilamellar morphology reminiscent of major histocompat-
ibility complex (MHC) class II containing compartments (MIICs)
[6]. Indeed, studies in cell culture systems, including antigen pre-
sentation assays, co-localization studies and sequencing of MHC
class II bound peptides, demonstrated that substrates of autophagy
can be loaded onto MHC class II for CD4+ T cell recognition. Animal
models to monitor or genetically disrupt macroautophagy now
provide the basis for elucidating the immunological relevance of
autophagy in vivo.
As this review focuses on the role of autophagy in mediating
CD4+ T cell responses and in regulating CD4+ T cell immunity
through processing and presentation of intracellular antigens onlsevier B.V. All rights reserved.
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antigen processing.
2. Antigen processing and presentation
T and B cells both express highly diverse receptors for antigen
whose enormous variability is established through somatic rear-
rangement of gene fragments during early development of the
respective lineage. Despite this similarity in the genetic makeup
of the T and B cell receptor, there is a fundamental difference in
how these two classes of lymphocytes recognize antigen: B cells
directly recognize antigens through interaction of their receptor
with free antigens or epitopes on the surface of supramolecular
structures (e.g. cells, bacteria, viruses), whereby these epitopes
can be made up of carbohydrates, lipids, proteins and even anor-
ganic compounds. By contrast, T cells primarily recognize rela-
tively small peptides that are generated by proteolytic
breakdown of protein substrates. These peptide snippets are not
recognized in free form, but have to be embedded in MHC mole-
cules on the surface of cells.
MHC molecules come in two ﬂavors, MHC class I and MHC class
II. Both classes of molecules share as a characteristic feature of
their tertiary structure a so-called peptide-binding groove, which
consists of two alpha helices outlining the rims of the peptide-
binding moiety and a beta sheet that forms the bottom of the
groove. Despite the overall very similar structure of MHC class I
and II molecules, the details of their tissue distribution, physiolog-
ical function and how the peptides they present to T cells are gen-
erated, are remarkably distinct. For instance, MHC class I is
expressed on essentially all tissues, whereas constitutive expres-
sion of MHC class II is restricted to so-called professional antigen
presenting cells (APCs) of hematopoietic origin and epithelial cells
of the thymus. Only upon exposure to interferon-c (IFNc), tissues
other than these will up-regulate MHC class II expression. Further-
more, whereas peptide/MHC class I (pMHCI) complexes represent
the ligands for the T cell receptor (TCR) of CD8+ cytotoxic T cells,
pMHCII complexes are recognized by CD4+ helper T cells. This
dichotomy in the recognition of pMHCI or II ligands by either cyto-
toxic or helper T cells, respectively, reﬂects the process of positive
selection during T cell development in the thymus. This rather
wasteful process ensures that immature T cells commit to the
CD8+ or CD4+ lineage according to the principal capacity of their
randomly rearranged TCR for MHC class I or II, respectively. As a re-
sult, cytotoxic T cells express the CD8 co-receptor, whereas helper
T cells express the CD4 co-receptor, which interact with non-poly-
morphic regions of MHC class I or II, respectively.
The basic principles of how peptides embedded in MHC class I
or II are generated have been well-established over the last two
decades (Fig. 1) [7]. Thus, MHC class II bound epitopes are primar-
ily generated through the proteolytic processing of proteins that
reach endosomal/lysosomal compartments subsequent to having
been taken up from the extracellular space. By contrast, MHC class
I bound peptides are mostly derived from proteasomal substrates,
that is, mis-folded cytoplasmic proteins that have been earmarked
for degradation by ubiquitination.
At ﬁrst glance, the paradigm that MHC class I or MHC class II
bound peptides originate from topologically distinct sources repre-
sents an elegant way how the immune system copes with the chal-
lenge that the eradication of intra- or extracellular pathogens
necessitates fundamentally different effector mechanisms. Thus,
the control of viral infections requires that those cells that have
been infected are eliminated by MHC class I-restricted CD8+ cyto-
toxic T cells. By contrast, the clearance of extracellular pathogens
such as most bacteria or helminths is largely dependent on anti-
body responses. In this case, MHC class II-restricted CD4+ helperT cells fulﬁll a critical pacemaker function for humoral immune re-
sponses in the form of cytokines that orchestrate the efﬁcient pro-
duction of antibodies by B cells.
A closer look, however, renders an absolutely strict topological
demarcation of the origin of MHC class I and MHC class II bound
peptides epitopes rather unlikely. For example, the initiation of
certain antiviral cytotoxic CD8+ T cell responses is dependent on
the MHC class I-restricted presentation of viral epitopes by den-
dritic cells (DCs), the major type of so-called ‘‘professional antigen
presenting cells”. Paradoxically, however, many viruses do not in-
fect DCs, and yet elicit strong cytotoxic T cell responses. This obser-
vation underscores the physiological relevance of an
‘‘unconventional” MHC I loading pathway that involves the shut-
tling of exogenous material, in this case viral proteins, into the
MHC class I loading pathway of DCs, a process termed cross-pre-
sentation [8]. Vice versa, early evidence for exceptions from the
‘‘rule” that MHC class II molecules are exclusively occupied by pep-
tides of extracellular origin was provided by the sequencing of pep-
tides eluted from MHC class II, revealing that around 20% of the
identiﬁed epitopes originated from intracellular sources such as
mitochondrial proteins, cytoskeletal proteins, metabolic enzymes,
chaperones and nuclear proteins [9].
How do epitopes derived from cytoplasmic proteins gain access
to MHC class II molecules? The candidate pathways implicated in
so-called ‘‘endogenous MHC class II loading” can be grouped into
two groups, depending on whether the intersection with the con-
ventional exogenousMHC class II loading pathway occurs upstream
or downstream of the proteolytic degradation of the substrate. The
ﬁrst category involves proteasomal antigen processing and subse-
quent TAP-mediated import of degradation products into the ER
and thus may be best described as ‘‘spill-over” from the MHC class
I pathway into MHC class II loading compartments [10]. The second
category encompasses a rather heterogeneousgroupofmechanisms
that deliver cytoplasmicmaterial for lysosomal degradation, includ-
ing chaperone-mediated autophagy and macroautophagy (re-
viewed in [11]). We will primarily focus on macroautophagy in
this review, because this pathwaywas frequently suggested to deli-
ver cytoplasmic material for MHC class II loading.
3. Autophagy substrates are loaded onto MHC class II molecules
More than a decade ago, the lab of Gitta Stockinger reported
that treatment of macrophages and B cells with the macroauto-
phagy inhibitor 3-methyl adenine (3-MA) prevented the presenta-
tion of an endogenously synthesized protein on MHC class II [12].
On this basis, these authors suggested that macroautophagy may
shuttle cytosolic proteins into MHC class II loading compartments.
In a subsequent study, Mautner and co-workers found that trans-
fection of a renal carcinoma cell line with a model antigen resulted
in the endogenous processing for MHC class II restricted presenta-
tion to CD4+ T cells, and again, this process could be inhibited by 3-
MA [13]. A caveat of both studies was that they involved the ecto-
pic over-expression of the respective model antigens. The ﬁrst
study to document a role for macroautophagy in loading of a phys-
iologically expressed cytoplasmic antigen dealt with the recogni-
tion of the nuclear antigen 1 (EBNA1) of Epstein Barr virus (EBV)
by CD4+ T cells. It was found that EBNA1 gains access to MHC class
II in EBV transformed B cells [14], and that EBNA1 was detectable
in autophagosomes when lysosomal proteolysis was inhibited [14].
Inhibition of macroautophagy by 3-MA or RNA interference direc-
ted against Atg12 strongly diminished recognition of these cell
lines by EBNA 1 speciﬁc CD4+ T cells [14]. In further support of a
role for macroautophagy in endogenous MHC class II loading, rec-
ognition of tumor antigen derived epitopes on MHC class II after
RNA transfection of DCs was reduced by 3-MA [15]. In support of
Fig. 1. Macroautophagy in MHC class II antigen processing. Antigens for MHC class I presentation are derived from proteins that are degraded in the cytosol by the
proteasome. Subsequent to their import into the endoplasmic reticulum (ER), peptides of 8–9 amino acids in length are loaded into the peptide-binding groove of MHC class I
molecules. Peptide-loaded MHC class I complexes are then exported through the Golgi apparatus to the cell surface for recognition by CD8+ T cells. MHC class II molecules
bind peptides generated in the endosomal–lysosomal systems and display them on the cell surface for recognition of CD4+ T cells. Extracellular antigens are taken up via
endocytosis/phagocytosis into endosomal compartments and are degraded by lysosomal proteases before they gain access to late endosomal MHC class II-loading
compartments (MIICs). The invariant chain (Ii) (shown in purple) protects the peptide-binding groove of MHC class II molecules from premature loading within the ER. In
MIICs, lysosomal proteases degrade the Ii, and the remaining peptide (CLIP for class II-associated Ii peptide) is exchanged for antigenic peptides. MHC class II molecules
occupied by high-afﬁnity peptides are then transported to the cell surface for CD4+ T cell immune surveillance. Besides this well-established ‘‘classical” exogenous MHC class
II loading pathway, there is now compelling evidence that a substantial proportion of MHC class II ligands are derived from intracellular proteins and that autophagic
pathways contribute to the delivery of these to the MIICs. During macroautophagy, which besides the proteasomal pathway represents a second major route of degradation of
intracellular constituents, cytoplasmic and nuclear antigens are enclosed in a double-membrane vesicle which then fuses with lysosomes and late endosomes to form
multivesicular and multilamellar compartments, called amphisomes. It is at this stage that an intersection with the ‘‘classical” MHC class II loading pathway is thought to
occur.
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demonstrated that macroautophagy is constitutively (i.e. even un-
der nutrient rich conditions) active at a relatively low but detect-
able level in a variety of MHC class II positive APCs such as DCs,
B cells and monocytes. Co-localization studies indicated that in
these cell types, autophagosomes indeed frequently fuse with
MHC class II-loading compartments, and deliberate experimental
delivery of a viral antigen to autophagosomes by targeting to the
autophagosomal membrane through fusion with Atg8/LC3, a ubiq-
uitin-like protein that gets covalently attached to the autophagic
membrane during macroautophagy, resulted in robust recognition
by speciﬁc CD4+ T cells [16]. The most direct evidence for delivery
of autophagy substrates to the MHC class II pathway was obtained
by eluting and sequencing MHC II bound epitopes before and after
switching to nutrient deprived conditions, indicating that starva-
tion induced macroautophagy resulted in a higher prevalence of
cytoplasm- or organelle-derived peptides [17].
4. Autophagy in positive and negative selection of the CD4+ T
cell repertoire
The ﬁrst in vivo situation that was identiﬁed to involve macro-
autophagy-mediated antigen processing for MHC class II presenta-tion is T cell selection. The speciﬁcity of the TCR on the surface of
individual thymocytes results from random somatic rearrange-
ment of gene segments at an early intrathymic developmental
stage. Inevitably, the stochastic nature of this process leads to
the emergence of T cells that carry receptors that are either ‘‘use-
less” or ‘‘harmful”: the former because they may not confer the
capacity to interact with self-MHC molecules at all, and the latter
because they may possess a speciﬁcity for self-antigens and hence
be potentially dangerous. In order to remove such speciﬁcities
from the T cell pool, the nascent T cell repertoire is subject to po-
sitive and negative selection [18]. For the sake of conceptual clar-
ity, it may in the context of this discussion be helpful to think of
these two processes as being spatially and temporally segregated
(although this is an issue of long-standing controversy). Thus,
immature thymocytes ﬁrst ‘‘test” the capacity of their TCR to en-
gage pMHC class I and pMHC class II complexes presented by cor-
tical thymic epithelial cells (cTECs), and T cell survival (‘‘positive
selection”) at this stage is contingent upon low afﬁnity interac-
tions. Furthermore, it is also on the basis of interactions with
pMHC ligands on cTECs that thymocytes commit to the CD4+ or
CD8+ lineage according to the capacity of their TCR to interact with
MHC class II or MHC class I, respectively. Remarkably, about 80–
90% of thymocytes fail to fulﬁll the criteria for positive selection
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translocate to medullary regions of the thymus where their TCRs
are tested for overt self-reactivity with MHC ligands on different
subsets of DCs as well as medullary thymic epithelial cells (mTECs).
Here, T cells that interact strongly with pMHC complexes on APCs
in the medulla are subject to negative selection (also known as
‘‘clonal deletion”).
The essential or at least signiﬁcant role of cTECs and mTECs for
positive selection or tolerance induction, respectively, provides an
obvious explanation for why these two developmentally related
thymic stromal cell subsets are the only non-hematopoietic cell
types that constitutively express MHC class II molecules. Remark-
ably, both cTECs and mTECs were found to be extremely inefﬁcient
in delivering epitopes derived from exogenous antigens onto MHC
class II, a feature that clearly distinguishes them from thymic DCs
[19]. On this basis, it was suggested that they may predominantly
present endogenously derived peptides on MHC class II [20]), and
the discovery in LC3-GFP transgenic, macroautophagy reporter
mice that TECs, and foremost cTECs, display an unusually high rate
of starvation independent, constitutive macroautophagy provided
an intriguing piece of evidence in favor of this idea [21]. More re-
cently, it has been reported that in both cortical and medullary
TEC lines, LC3 was colocalized with markers for MHC class II load-
ing compartments [22]. These results strongly suggest that cyto-
plasmic self-antigens expressed in the thymus gain access to
MHC class II loading via macroautophagy.
The hypothesis that macroautophagy in cTECs contributes to the
generation of pMHC class II ligands for positive selection was ad-
dressed using themacroautophagy deﬁcient Atg5/mousemutant
[23]. The neonatal lethality of Atg5/ mice, at least in part caused
by impaired bridging of a metabolic crisis related to the transition
from trans-placental to milk-derived nutrient supplies, precluded
a straight-forward assessment of T cell development in this system.
To circumvent this complication, embryonic thymi were trans-
planted under the kidney capsule of wild-type recipients, a well-
established procedure to study the effects of a particular genetic le-
sion speciﬁcally in TECs (in these grafts, hematopoietic cells, i.e. T
cells and DCs, turn-over and are eventually replaced by host-type
cells, whereas both cTECs and mTECs are replenished from a pre-
cursor pool of donor origin). It turned out that positive selection
of a number of MHC class II-restricted TCR speciﬁcities was affected
in the absence of macroautophagy in thymic epithelium [24]. Of
note, depending on the TCR tested, the alterations in the efﬁcacy
of positive selection could be either of detrimental or beneﬁcial nat-
ure, indicating that the general capacity of cTECs to support positive
selection was not impaired. Thus, the most likely explanation for
the effects of abrogated epithelial macroautophagy on positive
selection is that certain peptides that normally foster the positive
selection of particular TCR speciﬁcities may not or only inefﬁciently
be presented, while other, ‘‘macroautophagy-independent” ligands
may be over-represented under these circumstances.
A similar experimental set-up was also used to address whether
the polyclonal T cell repertoire generated in the absence of macro-
autophagy in TECs was self-tolerant. Here, athymic nudemice (that
due to a mutation in the Foxn1 transcription factor lack fully differ-
entiated TECs and consequently also a T cell system) were grafted
with Atg5/ or wild-type embryonic thymi. In such chimeras, the
graft is colonized by hematopoietic precursors and within about
four weeks, the peripheral lymphoid organs of these animals are
seeded with a T cell repertoire that has been ‘‘educated” by MHC
ligands on macroautophagy deﬁcient TECs. Quite dramatically,
many chimeras carrying an Atg5/ graft exhibited a substantial
weight loss starting from about ﬁve weeks after grafting. Histolog-
ical evidence and secondary transfers of peripheral T cells from dis-
eased animals conﬁrmed that these symptoms were caused by
immune-mediated tissue damage.In sum, the function of constitutive macroautophagy in TECs
may therefore be two-fold. First, macroautophagy may generate
endogenously derived MHC class II-bound peptides on cTECs for
positive selection of CD4+ T cells. Second, it is conceivable that
macroautophagy similarly shuttles cytoplasmic or organelle-de-
rived self-antigens into the MHC class II-loading pathway of
mTECs, in this case for tolerance induction within the nascent
CD4+ T cell repertoire. This latter scenario might be of particular
signiﬁcance considering that mTECs broaden the scope of self-anti-
gens available for central tolerance induction by ectopically
expressing a wide array of otherwise strictly tissue-speciﬁc self-
antigens [25].5. Harnessing autophagy to enhance CD4+ T cell immunity
In addition to its role in thymic T cell selection, MHC class II
loading after macroautophagy probably also contributes to the
priming of CD4+ T cell responses during infection and after vacci-
nation. This scenario is particularly relevant for intracellular patho-
gens that are restricted by macroautophagy and whose break-
down products could give rise to MHC class II ligands after degra-
dation in lysosomes. Thus, bacteria and parasites that either escape
from endosomes and replicate in the cytosol or condition the phag-
osome to serve as their replication niche – by preventing fusion
with lysosomes – have been found to be delivered for lysosomal
degradation via macroautophagy. Among these pathogens are
group A Streptococci, Listeria monocytogenes and Shigella ﬂexnerii,
which replicate in the cytosol after breaching the endosomal mem-
brane and may subsequently be engulfed by autophagosomes [26–
28].
The role of macroautophagy as an innate defense mechanism
against cytosolic bacteria seems to have forced successful patho-
gens to evolve evasion strategies. Thus, Listeria decreases engulf-
ment into autophagosomes by surrounding itself with coats of
cellular components. It induces an actin coat by ActA, independent
of the contribution of this protein to bacterial mobility [28], or by
hiding in incompletely listeriolysin O-permeabilized endosomes
[29]. Similarly, the VirA protein of Shigella, another protein in-
volved in bacterial actin-based mobility, is recognized by the
molecular macroautophagy machinery and can lead to selective
engulfment of these bacteria by autophagosomes [27], Shigella
blocks VirA recognition through expression of the IcsB protein,
resulting in bacterial evasion from macroautophagy.
Pathogens that condition their phagosomes after endocytic up-
take, like Mycobacterium tuberculosis or Toxoplasma gondii, can be
targeted for lysosomal degradation via stimulation of macroauto-
phagy [30–34]. As a cellular defense mechanism, these conditioned
phagosomes can be delivered to lysosomes via fusion with or
engulfment by autophagosomes. This macroautophagic clearance
of pathogen-conditioned phagosomes requires immunity-related
p47 GTPases such as immunity-related GTPase M (IRGM) and a6
(Irga6) [31,33,35–37]. Their recruitment to the bacterial phago-
some enhances fusion with lysosomes and subsequent clearance
of the pathogens. Interestingly, this innate restriction of intracellu-
lar pathogens is co-opted by the immune system for CD4+ T cell
priming. Thus, MHC class II presentation of the antigen Ag85B of
M. tuberculosis was found to be enhanced after stimulation of mac-
roautophagy through blockade of the mTOR pathway with rapa-
mycin [38]. Rapamycin treated DCs induced 2–6-fold higher CD4+
T cell responses against Ag85B after vaccination through adoptive
transfer into mice. Moreover, a combination of Ag85B-over-
expressing mycobacteria and induction of macroautophagy elic-
ited protective CD4+ T cell responses which controlled pathogen
titers in the lung at 1 log lower set-points. These ﬁndings suggest
that intracellular pathogen degradation, which on the one hand
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mune mechanism, at the same time also leads to the presentation
of pathogen-derived antigens on MHC class II molecules for the
induction of protective CD4+ T cell responses. Such an enhanced
MHC class II presentation after macroautophagy induction har-
bors obvious potential to increase the efﬁcacy of vaccination
strategies.6. Regulation of macroautophagy by immune signals
The ability of the host to successfully ﬁght off invading patho-
gens often relies on a tightly controlled interplay of innate and
adaptive immune mechanisms. The latter are largely controlled
by a group of germline-encoded receptors known as pattern-recog-
nition receptors (PRRs). These molecules include Toll-like recep-
tors, nucleotide-binding and oligomerization domain (NOD)-like
receptors, retinoic-acid-inducible gene I (RIG-I)-like helicases and
a subset of C-type lectin receptors, which endow cells of the innate
immune system with the ability to recognize a large number of
molecular patterns expressed by bacteria, viruses or fungi. Gener-
ally, the signaling pathways that are triggered by PRR ligation
through pathogen associated molecular patterns (PAMPs) lead to
cellular responses that range from increased antigen-presenting
capacity, for instance by the expression of co-stimulatory mole-
cules, to the production of soluble mediators such as type I inter-
ferons, pro-inﬂammatory cytokines and chemokines, which
orchestrate the immune response against the invading pathogen.
Recent data have revealed an intricate, mutual interplay be-
tween PRRs and macroautophagy, whereby macroautophagy on
the one hand facilitates the recognition of cognate ligands by PRRs
by fostering their physical interaction, and on the other hand
serves as an immune effector mechanism downstream of PRR stim-
ulation. For example, intracellular replication intermediates of
vesicular stomatitis virus (VSV), recognized by PRRs, are delivered
to endosomally located TLR7 by macroautophagy, which results in
robust type I interferon-dependent innate immune responses by
plasmacytoid DCs (pDCs) [39]. As an effector mechanism, PRR sig-
naling can induce or augment macroautophagy [40,41]. In this con-
text, intracellular PRRs rather than receptors that survey the
extracellular environment may be key candidates for linking path-
ogen sensing with macroautophagy induction. For instance, insect
cells rely on intracellular peptidoglycan-sensing molecules to trig-
ger macroautophagy following L. monocytogenes infection [42].
This autophagic response appears to be required for the control
of L. monocytogenes infection and survival of the host. Likewise,
the intracellular PRRs Nod1 and Nod2, which sense peptidoglycan
moieties released from bacterial cell walls, can act as nucleation
sites for macroautophagy initiation following bacterial infection
in mammalian cells [43]. Nod1 and Nod2 recruited the macroauto-
phagy protein ATG16L1 to the plasma membrane at the bacterial
entry site, and the physiological relevance of this ﬁnding is bol-
stered by the observation that function-altering Nod2 mutations
lead to impaired wrapping of invading bacteria by autophago-
somes [43]. Thus, macroautophagy does not only target PAMPs to
endosomal PRRs for immune recognition, but is also actively con-
trolled by PRR stimulation, suggesting that PRR signaling pathways
could be exploited for the elimination of intracellular pathogens
through induction of macroautophagy.
Besides PRR signaling, cytokines such as interferons (IFNs) and
members of the tumor necrosis factor (TNF) family also are capable
of modulating macroautophagy. Restriction of HSV-1 infection by
macroautophagy in vitro and in vivo was found to be dependent
on type I IFN signaling [44]. IFN-gamma has been reported to en-
hance M. tuberculosis and Ricksettia conorii degradation by macro-
autophagy in infected cells [30,31]. Interestingly, whereas IFN-gamma induces macroautophagy and mycobacterial clearance –
through a mechanism that involves immunity-related GTPases
(IRGs) – [45], Th2 signature cytokines such as interleukin (IL)-4
and IL-13 appear to inhibit IFN-gamma induced autophagic deliv-
ery of mycobacteria into degradative compartments [46]. While
the complex regulation of macroautophagy by cytokines is only
incompletely understood, it deserves mentioning that mouse tis-
sues are probably more susceptible to IFN-gamma-mediated mac-
roautophagy induction because their IRGs are IFN-gamma
inducible (in contrast to those of humans), indicating that immune
signals that stimulate macroautophagy can differ between rodents
and man.
Concerning TNF-family pathways, TNF-alpha was found to up-
regulate macroautophagy in cells lacking NF-kB activation [47]
and TNF-related apoptosis-inducing ligand (TRAIL) was described
to induce macroautophagy in human epithelial cells [48]. Consis-
tent with this, inactivation of Fas-associated death domain (FADD),
the signaling adapter protein of the TRAIL receptor, decreases mac-
roautophagy induction by TRAIL [49]. As a third TNF-family mem-
ber, CD40L has been demonstrated to induce macroautophagy-
mediated fusion of T. gondii-containing phagosomes with lyso-
somes through CD40 signaling on mouse and human macrophages
[32]. Together, these ﬁndings suggest that the immune-mediated
regulation of macroautophagy via cytokines or membrane-bound
molecules could represent a feedback mechanism by which acti-
vated T cells augment macroautophagy under inﬂammatory
conditions.7. Conclusions and outlook
A growing body of evidence indicates that the immune system
employs macroautophagy for the immune surveillance of cytoplas-
mic compartments and the eventual clearance of intracellular
pathogens. The ‘‘non-classical” presentation of autophagosomal
substrates on MHC class II, supposedly enhanced under inﬂamma-
tory conditions, represents another example of the intricate cross-
talk between the innate and the adaptive arms of the immune
system. As a mechanism involved in the steady-state turnover of
cellular components, macroautophagy does not only shuttle path-
ogen-derived foreign antigens, but presumably also self-antigens
into the MHC class II pathway. The necessity to prevent the im-
mune system from mounting an autoreactive response against
these intracellular self-antigens may have driven the evolution of
a mechanistically as yet poorly understood unusually high rate of
starvation- and inﬂammation-independent macroautophagy in
TECs. This phenomenon was shown to contribute to CD4+ T cell
selection and is essential for the generation of a self-tolerant T cell
repertoire. Future work will establish whether macroautophagy, in
addition to its function in thymic T cell selection, is similarly in-
volved in the maintenance of peripheral tolerance within the
CD4+ T cell compartment.
Recent studies have also suggested a role for macroautophagy
in regulating intracellular antigen processing for MHC class I pre-
sentation and in packaging antigens for optimal cross-presentation
on MHC class I molecules [50,51]. While these additional pathways
require further investigation to understand the underlying mecha-
nisms, autophagy-mediated antigen delivery to both MHC class II
and MHC class I molecules should be explored for its potential to
increase the efﬁcacy of vaccination strategies, to enhance adaptive
immune responses during chronic infections or to limit inﬂamma-
tory tissue damage in T cell-driven autoimmune diseases. Future
studies might provide a more precise understanding of how and
by which mechanisms autophagy regulates T cell immunity and
tolerance during health and disease in vivo and how this pathway
could be harnessed for vaccination and immunotherapy.
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